Private defence production, Government agency

New Delhi, June 1 The Defence Research and Development Organisation (DRDO) on Tuesday issued directions on how to use the new drug called 2-DG for Covid patients.The drug can be given to patients under the care and prescription of doctors as it issued directions for its use."Ideally, 2DG should be prescribed as early as possible by doctors for moderate to severe Covid patients for a maximum duration of up to 10 days," DRDO said in a statement.The first batch of DRDO-developed anti-Covid drug was launched last month to treat patients suffering from the deadly disease.The medicine comes in powder form and can be taken with water.The DRDO said that the patients of uncontrolled diabetes, severe cardiac problem, acute respiratory distress syndrome (ARDS), severe hepatic and renal impairment have not been studied yet so they need to exercise caution.The anti-Covid drug should not be given to pregnant and lactating women and patients below 18 years, it said.The drug could be a game-changer in the battle against the pandemic as it helps in faster recovery of hospitalised patients and reduces oxygen dependence.Clinical trial results have shown that the drug helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in Covid patients.The medicine was found to be safe for Covid-19 patients in Phase 2 trials, conducted between May and October last year. It was found to be effective in cutting short the hospital stays of Covid patients and reducing their supplemental oxygen dependence.During the first wave of the pandemic in April last year, INMAS-DRDO scientists conducted laboratory experiments with the help of the Centre for Cellular and Molecular Biology (CCMB), Hyderabad, and found that this molecule works effectively against SARS-CoV-2 virus and inhibits the viral growth.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Private Defence ProductionFOLLOW

Private defence production, Latest News

Union Minister of State for Home Affairs G Kishan Reddy met Jammu and Kashmir's Lieutenant Governor Manoj Sinha at Raj Bhavan on Sunday. ...

In what would be a major boost for the submarine building capability within the country, the first three nuclear attack submarines to be built indigenously would be having 95 per cent Made in India content in them and it would further go up in the ne ...

Srinagar, June 9 The Lieutenant Governor of Jammu and Kashmir, Manoj Sinha, on Wednesday inaugurated a 500-bed Covid ... ...

The Defence Research and Development Organisation (DRDO), which developed 2 -Deoxy-D-Glucose (2-DG), a drug used for the treatment of COVID-19 patients, has called for Expression of Interest (EoI) to transfer the technology to Indian pharmaceutical i ...

Jammu and Kashmir Lieutenant Governor Manoj Sinha on Wednesday inaugurated a 500-bedded Defence Research and Development Organisation (DRDO) COVID-19 hospital with an ICU facility, at Khonmoh in Srinagar. ...

The Defence Research and Development Organisation (DRDO), which developed 2 -Deoxy-D-Glucose (2-DG), a drug used for the treatment of COVID-19 patients, has called for Express of Interest (EOI) to transfer the technology to Indian pharmaceutical indu ...

A 500-bed Covid-19 hospital in Khonmoh area of Srinagar is in final stages of completion and will soon be open to the public. ...

New Delhi, June 1 The Defence Research and Development Organisation (DRDO) on Tuesday issued directions on how to ... ...